MSD Homemerck.com home

MSDHIV.COM - Integrase Inhibition Integrase

  

Integrase Inhibition
Integrase Inhibition - Mechanism of Action
Integrase Inhibition - Study Summaries
MSDHIV - Resources
Commitment to HIV/AIDS
MSDHIV - Conferences
MSDHIV - Posters
MSDHIV - Slide Sets
MSDHIV - Webcast

Privacy Policy

 

RESOURCES— Webcasts

Congress Presentations
11th European AIDs Conference (EACS)
Madrid, Spain, 24-27 October 2007
Provided as a service to the medical profession by Merck Sharp & Dohme. The views expressed in these presentations reflect the experiences and opinions of the presenters and does not necessarily reflect the opinions and recommendations of Merck Sharp & Dohme. Please consult the full prescribing information prior to prescribing any drug discussed in these presentations.

• Evolution of HIV Therapy — Great Achievements, Greater Challenges
Jürgen Rockstroh (Germany)
• HIV Management in the 21st Century: The Promise of New Agents
Bonaventura Clotet (Spain)
• ISENTRESS, The First of a New Class of Integrase Inhibitors: Clinical Overview
Bach-Yen Nguyen (United States of America)
• ISENTRESS in Clinical Practice — a Real World Experience
Jacques Reynes (France)
• Panel Discussion

 
 


Due to individual countries' requirements, not all uses or indications discussed in this Web site may have received regulatory approval in your country. Before prescribing any of the products mentioned in this Web site, please consult the local prescribing information available from the manufacturer.

†Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA
Contact MSD Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.